Difference between revisions of "WSI23-10-Case-8"
From MGH Learn Pathology
(Created page with "{{ServiceRequestCase |subject=MGH |intent=order |category=PGY2 |occurrenceDateTime=2023/02/16 12:00 |basedOn=WSI23-10 |priority=routine |code=apdidactic |orderDetail=case |aut...") |
(Added status template) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
|basedOn=WSI23-10 | |basedOn=WSI23-10 | ||
|priority=routine | |priority=routine | ||
| − | |code= | + | |code=study |
|orderDetail=case | |orderDetail=case | ||
|authoredOn=February 03, 2023 01:48:03 PM | |authoredOn=February 03, 2023 01:48:03 PM | ||
|requester=Aja51 | |requester=Aja51 | ||
|locationCode=learn | |locationCode=learn | ||
| − | |sequence= | + | |sequence=7 |
|performer=RH27 | |performer=RH27 | ||
|bodySite=BONE MARROW BIOPSY | |bodySite=BONE MARROW BIOPSY | ||
| − | |reasonCode=68 year old man with history of MDS on luspatercept | + | |reasonCode=68 year old man with history of MDS on luspatercept. |
| − | |supportingInfo=MDS with RS and erythroid predominance (MDS with mutated SF3B1). | + | |supportingInfo=MDS with RS and erythroid predominance (MDS with mutated SF3B1). WBC 2.7 (41% polys, 2% bands, 40% lymphs, 11% monos, 2% eos, 4% basos), HGB 7.3, MCV 94.6, PLT 420. |
}} | }} | ||
{{Media | {{Media | ||
| Line 46: | Line 46: | ||
|view=show | |view=show | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Aja51 | ||
| + | |authoredOn=February 03, 2023 01:48:03 PM | ||
}} | }} | ||
Latest revision as of 14:43, December 9, 2024
